Dysuria therapeutic agents as an independent prognostic factor for the primary recurrence of non-muscle invasive bladder cancer: a propensity score matching study.
Yoichiro KatoDaiki IkarashiDaichi KikuchiMisato TakayamaSeiko KanzakiAkito ItoDaichi TamuraTomohiko MatsuuraShigekatsu MaekawaRenpei KatoMitsugu KanehiraRyo TakataJun SugimuraWataru ObaraPublished in: The Journal of international medical research (2021)
Therapeutic agents for dysuria might be at an independent risk factor for NMIBC recurrence. This trial is registered with the UMIN Clinical Trials Registry under the number UMIN000036097 (https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno = R000041122).